À¶Ý®ÊÓÆµ

Akero Investor Suit Over Liver Drug Trials Permanently Tossed

By Gina Kim ( August 18, 2025, 6:33 PM EDT) -- A California federal judge has permanently ended Akero Therapeutics investors' proposed class action alleging they were misled about the patient population in the company's liver disease treatment clinical trial, ruling the investors did not "fill-in the logical gaps" she previously identified when dismissing their earlier pleading for failing to plead scienter. ...

À¶Ý®ÊÓÆµ is on it, so you are, too.

A À¶Ý®ÊÓÆµ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A À¶Ý®ÊÓÆµ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience À¶Ý®ÊÓÆµ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login